Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Avanos Medical Inc (AVNS)

Avanos Medical Inc (AVNS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,369,165
  • Shares Outstanding, K 47,756
  • Annual Sales, $ 697,600 K
  • Annual Income, $ -45,900 K
  • 60-Month Beta 1.19
  • Price/Sales 2.01
  • Price/Cash Flow 16.03
  • Price/Book 1.12

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.07
  • Number of Estimates 4
  • High Estimate 0.07
  • Low Estimate -0.16
  • Prior Year 0.28
  • Growth Rate Est. (year over year) -125.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.09 +5.83%
on 06/26/20
33.95 -15.55%
on 06/10/20
-5.12 (-15.15%)
since 06/09/20
3-Month
24.71 +16.03%
on 05/14/20
34.53 -16.97%
on 06/08/20
-0.28 (-0.97%)
since 04/09/20
52-Week
19.46 +47.33%
on 03/23/20
48.07 -40.36%
on 11/04/19
-14.62 (-33.77%)
since 07/09/19

Most Recent Stories

More News
Here's Why You Should Retain Avanos Medical Stock for Now

Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.

DGX : 115.85 (-1.76%)
SRDX : 41.33 (-1.50%)
LH : 173.12 (-0.77%)
AVNS : 28.67 (-2.28%)
MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings

Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital Management

MDT : 90.13 (-1.62%)
BIIB : 278.70 (-0.53%)
AVNS : 28.67 (-2.28%)
ABMD : 265.68 (+0.02%)
Avanos Medical (AVNS) Up 0.1% Since Last Earnings Report: Can It Continue?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AVNS : 28.67 (-2.28%)
Avanos Medical, Inc. to Present at Two Virtual Investor Conferences in June

, /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in June:

AVNS : 28.67 (-2.28%)
Here's Why You Should Retain Avanos Medical Stock for Now

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, stiff competition remains a concern.

HMSY : 32.25 (-0.77%)
WST : 235.93 (+1.56%)
AVNS : 28.67 (-2.28%)
APHA : 4.19 (-2.78%)
Avanos Medical (AVNS) Q1 Earnings Lag Estimates, Revenues Top

Avanos Medical's (AVNS) first-quarter results benefit from segmental contribution.

BIIB : 278.70 (-0.53%)
LLY : 166.45 (-1.58%)
AVNS : 28.67 (-2.28%)
APHA : 4.19 (-2.78%)
Avanos Medical (AVNS) Lags Q1 Earnings Estimates

Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.88% and 4.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

AVNS : 28.67 (-2.28%)
Avanos Medical, Inc. Announces First Quarter 2020 Results and Provides an Update on its Response to the COVID-19 Pandemic

, /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2020 financial results and provided an update on the actions it's taking in response to the COVID-19 pandemic.

AVNS : 28.67 (-2.28%)
Here's Why You Should Hold on to Avanos Medical Stock Now

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.

MCK : 140.89 (-2.55%)
MMSI : 43.24 (-1.23%)
COO : 289.73 (+3.45%)
AVNS : 28.67 (-2.28%)
Why Is Avanos Medical (AVNS) Down 30.2% Since Last Earnings Report?

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AVNS : 28.67 (-2.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade AVNS with:

Business Summary

Avanos Medical Inc. operates as a medical technology company. It offers infection prevention, surgical, respiratory, digestive health and pain management solutions. Avanos Medical Inc., formerly known as Halyard Health Inc., is headquartered in Alpharetta, Georgia.

See More

Key Turning Points

2nd Resistance Point 29.77
1st Resistance Point 29.22
Last Price 28.67
1st Support Level 28.11
2nd Support Level 27.55

See More

52-Week High 48.07
Fibonacci 61.8% 37.14
Fibonacci 50% 33.76
Fibonacci 38.2% 30.39
Last Price 28.67
52-Week Low 19.46

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar